Introduction
Growth factors and their receptors play important roles not only in the regulation of cell proliferation, but also in the pathogenesis of human cancers (Nguyen and Schrump, 2004) . Abnormalities in their expression and associated signaling pathways contribute to the progression and maintenance of the malignant phenotype seen in human cancers (Cance and Liu, 1995) . Deregulation of epidermal growth factor receptor (EGFR) activation has been shown to be closely related to the pathogenesis and progression of human breast, head and neck, bladder, prostate, kidney, non-small-cell lung cancer, and glioblastoma (Yarden and Sliwkowski, 2001 ). The binding of epidermal growth factor (EGF) to its receptor induces a conformational change in the receptor, resulting in the autophosphorylation of tyrosine residues within the cytoplasmic domain of EGFR. Autophosphorylated EGFR can be bound by Src and other Src homology 2 (SH2) domain-containing proteins. Binding to EGFR activates Src kinase, possibly by relieving the autoinhibitory effect of the Src C-terminal peptide (Biscardi et al., 1999) . Subsequently, Src phosphorylates EGFR at several tyrosine residues that are not targeted by the receptor's autophosphorylation mechanism, including Tyr845, which is essential for EGF-induced cell proliferation (Biscardi et al., 1999) . Src mediates EGF-induced activation of ERK1/2 (Mason et al., 1999; Bivona et al., 2003) , and PI3K/Akt pathways (Jiang and Qiu, 2003; Kong et al., 2003; Lu et al., 2003) as well as STAT3/5, PLCg-1 and other targets (Mason et al., 1999; Olayioye et al., 1999; Bivona et al., 2003; Kong et al., 2003) . The bi-directional interaction of EGFR and Src leads to a synergy in promoting cell transformation and tumorigenesis . Meanwhile, some proteins that are activated by Src also participate in the downregulation of EGFR signaling. For example, Src phosphorylates clathrin and dynamin, which take part in receptor endocytosis and degradation. The Src substrate, Cbl, which is an E3 ubiquitin ligase, promotes receptor degradation through the proteosome pathway (Kassenbrock et al., 2002) . Thus, Src integrates both positive and negative feedback regulation of EGFR signaling. However, the regulation mechanisms of Src itself, such as the mechanism for terminating EGFinduced Src activation, have not been elucidated.
Csk (C-terminal Src kinase)-binding protein (Cbp), which is also called phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), is a ubiquitously expressed transmembrane adaptor protein (Kawabuchi et al., 2000; Brdicka et al., 2000) . Cbp is exclusively localized to microdomains, where Src family kinase (SFK) is also found to be enriched (Simons and Ikonen, 1997; Brdicka et al., 2000) . When tyrosine is phosphorylated, Cbp recruits Csk from the cytosol to the microdomains, where Csk suppresses SFK activity. This has been observed mainly in lymphocytes (Brdicka et al., 2000; Ohtake et al., 2002; Baumgartner et al., 2003; Davidson et al., 2003) .
As mentioned above, the interactions between Src and EGFR play important roles in regulating EGF-induced signal transduction and cell transformation. Therefore, we examined whether the ubiquitously expressed adaptor protein Cbp is involved in regulation of EGFR-induced cell signaling. Our findings indicated that EGF-stimulation-induced Cbp association with Csk, and that the Cbp-Csk complex participated in the downregulation of EGF-induced Src activation, cell transformation and colony formation. In addition, our data also suggested that Cbp may be involved in signal transduction initiated by multiple receptor tyrosine kinases (RTKs).
Results
Epidermal growth factor induces Cbp tyrosine phosphorylation and Cbp-Csk association Adaptor role of Cbp depends on its regulated tyrosine phosphorylation state. Here we explored the possible involvement of Cbp in EGF-induced cell signaling by checking its tyrosine phosphorylation in human epithelial carcinoma cell line A431 and HEK 293. Immunoblots with anti-pY antibody revealed that EGF-stimulation-induced tyrosine phosphorylation of endogenous Cbp in both A431 and HEK 293 cells ( Figure 1a , upper panel). Co-immunoprecipitation of Csk with Cbp was readily detected in EGF-stimulated cells, indicating that their association is dependent on Cbp tyrosine phosphorylation ( Figure 1a , middle panel). The EGF stimulation-dependent Cbp-Csk association was confirmed by reverse immunoprecipitation with anti-Csk antibody (Figure 1b) . The association of Cbp with Csk was not detected in immunoprecipitation with nonimmune serum (NS) (data not shown). These results indicate that Cbp is involved in EGF-induced signaling.
Epidermal growth factor-induced Cbp tyrosine phosphorylation depends on SFK activity There are a total of ten tyrosine residues in the amino acid sequence of human Cbp, and nine of them are located within potential consensus sequences for phosphorylation by SFK (YXXV/L/I) (Brdicka et al., 2000) .
Hence, the SFK inhibitor PP2 was used to examine the possible involvement of SFK in EGF-induced Cbp tyrosine phosphorylation. In PP2-treated A431 and HEK 293 cells, Cbp tyrosine phosphorylation and Cbp-Csk association were completely abolished, even in EGF-unstimulated cells (Figure 2a and b) . However, EGF-induced tyrosine phosphorylation of Shc, which is one of the major substrates of EGFR, was not affected by PP2 treatment (Figure 2a , bottom panels), indicating that PP2 has no effect on the activity of EGFR. In addition, overexpression of wild-type Src, but not kinase inactive Src mutant (SrcK295R), strongly induced tyrosine phosphorylation of endogenous Cbp in HEK 293 cells (Figure 2c ). Exogenous expression of wt Csk slightly suppressed Cbp tyrosine phosphorylation, whereas the expression of the dominant-negative Csk (CskK222R), at an equivalent level, enhanced Cbp phosphorylation (Figure 2d ). These results indicate that Src is required for Cbp tyrosine phosphorylation induced by EGF.
Tyr317 of Cbp mediates Cbp-Csk association
It has been reported that a point mutation of murine Cbp at the Tyr314 residue abrogated its binding to Csk (Kawabuchi et al., 2000) . A construct of human Cbp was generated in which Tyr317, the counterpart of Tyr314 in murine Cbp, was substituted with phenylalanine (CbpY317F). Cbp/wt and CbpY317F were transiently transected into BHK/EGFR cells and stimulated with EGF or left untreated. Immunoprecipitations with antibodies against Cbp followed by immunoblotting with anti-pY antibody revealed that tyrosine phosphorylation of Cbp/wt strongly enhanced upon EGF-stimulation. In comparison to Cbp/wt, tyrosine phosphorylation of CbpY317F was dramatically decreased (Figure 3a) , suggesting that Cbp Y317 is the major tyrosine phosphorylation site induced by EGF. Association of Cbp with Csk was detected in Cbp/ wt-expressing cells, but not CbpY317F-expressing cells by reprobing with Csk antibody (Figure 3a) . The role of Cbp Y317 in mediating Cbp-Csk association was further confirmed by co-immunoprecipitations using stable NIH3T3/Cbp, NIH3T3/CbpY317F, MDA-MB-468/Cbp, and MDA-MB-468/CbpY317F cells. Epidermal growth factor stimulation clearly induced Cbp-Csk association in Cbp/wt-expressing cells but not in CbpY317F-expressing cells (Figure 3b and c). The expression level of endogenous Csk in BHK/EGFR, NIH3T3, and MDA-MB-468 cells was not changed when Cbp overexpressed (data not shown). An in vitro pull-down assay using GST-Csk fusion proteins was performed to map the Cbp binding site in Csk. Sodium pervanadate, the pan-inhibitor of protein tyrosine phosphatases, was used to induce tyrosine phosphorylation of Cbp. Figure 3d demonstrates Cbp binding to the Csk SH2 domain but not to the Csk SH3 domain. These results support that the Cbp is directly associated with Csk via phosphorylated Cbp Y317 and Csk SH2 domain.
Expression of CbpY317F and Cbp knockdown diminishes the amount of Csk within microdomains Cbp, EGFR and Src have been reported to be localized within the microdomains (Lisanti et al., 1994; Smart et al., 1995; Kawabuchi et al., 2000) . As shown in Figure 4a , Cbp, EGFR, and Src were all enriched in the same fractions where the microdomain-characteristic protein caveolin-1 was present. Csk was also detected in the same fractions in A431 cells, which might possibly be due to its associations with Cbp or other proteins (Figure 4a ). Interestingly, an EGF-stimulation-independent interaction of Cbp with caveolin-1 was discovered through co-immunoprecipitation with anti-Cbp antibody, but not with NS ( Figure 4b ). Expression levels of Cbp and caveolin-1 were not changed by EGF stimulation ( Figure 4c ). These data suggest a close localization of EGFR, Src, Cbp, Csk and caveolin-1 in the microdomains. In NIH3T3 cells, EGF stimulation was able to increase the amount of Csk within microdomains (data not shown), which consistent with the published data by other group (Matsuoka et al., 2004; Zhang et al., 2004) . To investigate the contribution of Cbp to recruitment of Csk to microdomains, we purified microdomains from EGF stimulated NIH3T3 cells ( Figure 5 ). Expressing CbpY317F or Cbp knockdown notably diminished the amount of Csk in microdomains of NIH3T3 cells in comparison to their mock cells, respectively (Figure 5a and b) . These results indicated that Cbp is the major protein that recruits Csk to microdomains in NIH3T3 cells upon EGF-stimulation.
Cbp negatively regulates epidermal growth factor-induced Src, ERK1/2, and Akt-1 activation As the association of Cbp with Csk was induced by EGF-stimulation, we asked whether Cbp was involved in the regulation of EGF-induced activation of Src tyrosine kinase and/or other key enzymes, for instance, extracellular signal-regulated protein kinases (ERK1/2) and protein kinase B/Akt-1. To address this point, the BHK/EGFR cells was transiently transfected with Cbp/ wt or CbpY317F. Anti-Src(pY416) antibodies were used to monitor EGF-induced Src activation. As shown in Figure 6a , the antibody clearly detected bands with stronger signals in empty vector-and CbpY317F-transfected cells than in Cbp/wt-transfected cells after EGF stimulation, suggesting that elevated expression of Cbp/wt reduced the EGF-induced Src activation. The effect of Cbp on regulating EGF-induced ERK1/2 and Akt-1 activation was determined by using anti-ERK1/ 2(pT202/pY204) and anti-Akt(pS473) antibodies. Western blot analysis revealed that the EGF-induced activation of both ERK1/2 and Akt-1 were suppressed by overexpression of Cbp/wt compared to the mock cells and, in contrast, enhanced by the expression of CbpY317F (Figure 6a ). Epidermal growth factorinduced tyrosine phosphorylation of overall proteins was not affected by the expression of Cbp/wt or CbpY317F (Figure 6b ).
To further confirm the regulatory role of Cbp in EGF-induced signaling, we generated two stable NIH3T3 cell lines in which Cbp/wt and CbpY317F were overexpressed (Figure 7a ). Like the BHK/EGFR cells, expression of Cbp/wt significantly inhibited EGFinduced Src activation in NIH3T3 cells (Figure 7b and c). The activation of EGF-induced ERK1/2 and Akt-1 was also markedly suppressed in Cbp/wt-expressing cells (Figure 7b, d and e) . Likewise, we observed that in CbpY317F-expressing cells, EGF stimulation significantly enhanced Akt-1 activation compared to control cells and Cbp/wt-expressing cells (Figure 7b and e). To further prove the requirement of Cbp for EGF-signaling, RNA interference approach was employed to knockdown endogenous Cbp in NIH3T3 cells. Expression of human Cbp RNAi nucleotide (CbpRiH) had no effect on the expression of Cbp in NIH3T3 cells ( Figure 7f ). As shown in Figure 7g , EGF-induced Src, ERK1/2, and Akt-1 activation was significantly increased in Cbp knockdown cells (Figure 7g and h) . Taken together, our data suggest that Cbp plays a role in negative regulation of EGFR-initiated signaling through the Cbp-Csk-Src pathway.
Cbp-Csk association regulates epidermal growth factor-induced cell transformation It was reported previously that overexpression of EGFR in NIH3T3 cells resulted in an EGF-dependent transformation phenotype (Di Fiore et al., 1987) . To determine the potential effects of Cbp on EGF-induced cell transformation, a focus formation assay was performed in the NIH3T3 stable cell lines expressing Cbp/wt (pool, and clone 7) and CbpY317F (pool, and clone 18), respectively, which were infected or left uninfected with EGFR-expressing retrovirus. The expression levels of Cbp and its mutant in the transfectants are shown in Figure 7a . All foci occurred only in those NIH3T3 cells that were infected with EGFR and treated with EGF (Figure 8a ). This result was consistent with previous findings (Di Fiore et al., 1987) . As expected, the cells expressing Cbp/wt clearly formed fewer foci than did the mock cells or the cells expressing CbpY317F (Figure 8a and b) . In contrast to the Cbp/ wt-expressing cells, CbpY317F-expressing cells formed significantly more foci than did the mock cells ( Figure  8a and b) . Furthermore, Cbp and its mutant displayed stronger effects on the regulation of EGF-induced cell transformation in the two selected cell clones with more expression of Cbp/wt and CbpY317F compared to the pool cells (Figures 7a and 8a, b) . Moreover, ability of cellular transformation in the Cbp knockdown cells was significantly increased in comparison to the mock cells in response to EGF treatment (Figure 8c and d ). These results demonstrate that the Cbp-Csk association may generate a negative signal to downregulate EGFRinitiated cell transformation.
Cbp-Csk association downregulates tumor cell growth in soft agar
To explore the possible functions of Cbp in tumor cell growth, Cbp expression in 17 breast cancer cell lines was screened by Northern blot analysis. We found that several cell lines, including MDA-MB-468, exhibit relatively low expression levels of Cbp (data not shown). In order to investigate the effect of Cbp on the growth of MDA-MB-468 cells, we generated two transfectants of MDA-MB-468, which stably expressed Cbp/wt and its mutant CbpY317F, respectively ( Figure 9a ). As shown in Figure 3b , the EGF-induced Cbp-Csk association was detected only in the MDA-MB-468/Cbp/wt cells, but not in the MDA-MB-468/CbpY317F cells. Soft agar analysis revealed that the capability of colony formation of MDA-MB-468/Cbp/wt cells was significantly slower than that of the control cells. In contrast to the MDA-MB-468/Cbp/wt cells, the expression of CbpY317F significantly augmented cell growth and colony formation (Figure 9b) . Representative pictures are shown in Figure 9c .
Cbp is involved in multiple RTKs-signal transduction pathways
In an examination of whether Cbp was involved in RTK signal transduction pathways, PDGFR, FGFR-1 or TrkA were transiently overexpressed in HEK 293 cells and the tyrosine phosphorylation state of endogenous Cbp was analysed. All three RTKs (FGFR-1, TrkA, and PDGFR) were able to induce Cbp tyrosine phosphorylation (Figure 10 ).
Discussion
It is likely that a complex interaction exists between receptor and nonreceptor protein tyrosine kinases to transmit transformation signals following growth factor stimulations. We set out to determine whether Cbp and Csk regulate the EGF-induced signal transduction pathway in epithelial cells. Our results demonstrated that: (1) a negative feedback loop is formed by Cbp, Csk, and Src kinase in EGF signaling; (2) the EGF-induced Cbp-Csk complex inhibits activation of ERK1/2 and Akt-1; (3) the Cbp-Csk complex represses EGFR-generated NIH3T3 cell transformation via downregulation of Src kinase activity; and (4) overexpression of Cbp suppresses colony formation of MDA-MB-468 breast carcinoma cells in soft agar. These findings highlight a critical role of Cbp in EGFsignaling and tumorigenesis.
To address the mechanism of Cbp action, wild-type Cbp and phosphorylation-defective Cbp mutants, Cbp RNAi were expressed in NIH3T3 cells. The analyses revealed that overexpression of wild-type Cbp led to a significant inhibition of EGF-induced cellular signaling and transformation. In contrast, the phosphorylationdefective Cbp mutant CbpY317F and Cbp knockdown enhanced these EGFR-triggered responses. In addition to demonstrating the importance of tyrosine phosphorylation for the inhibitory function of Cbp, the dominant-negative effect of CbpY317F as well as Cbp RNAi implied that the inhibitory impact of wild-type Cbp was not a spurious effect of overexpression. Rather, it reflected the true function of endogenous Cbp molecules. As Csk is a cytoplasmic kinase, while SFK is membrane anchored, Csk has to be transferred to the cell membrane to target the SFK C-terminal. Our results indicate that the Cbp-Csk association produced a negative feedback loop in EGFR signaling. Once bound by the ligand, EGFR molecules dimerize, autophosphorylate and recruit the Src kinase. The association of EGFR and Src results in Src activation and further EGFR activation. Meanwhile, Src phosphorylates Cbp, which then recruits Csk to terminate the activation of Src.
Several lines of evidence indicated that Cbp inhibits EGF-signaling primarily by recruiting Csk and inactivating Src kinase. First, we found that the inhibitory influence of Cbp was eliminated by mutation of Y317, the major Csk-binding site of Cbp. However, the possibilities that this site and other domains of Cbp, such as SH3-binding domains, may bind to other SH2 and SH3 domain-containing molecules cannot be excluded. Second, overexpression CbpY317F impairs translocation of Csk into microdomains, an effect analogous to that observed upon Cbp knockdown. Although there were two conflictive reports about the localization of Csk in microdomains of Cbp À/À cells (Dobenecker et al., 2005; Xu et al., 2005) , our data support that Cbp plays an important role in recruitment of Csk to microdomains upon EGF stimulation. And lastly, knockdown of Cbp results in augmentation of EGFR-initiated signaling pathway.
Previously, many SH2-binding proteins of Csk have been reported, such as FAK (Tremblay et al., 1996) and Paxillin (Cao et al., 2004) , PTP-HSCF (Wang et al., 2001) , and vascular endothelial cadherin (Baumeister et al., 2005) . Recently, caveolin-1 was found to be phosphorylated by Src kinases in response to insulin and EGF treatment (Kim et al., 2002; Cao et al., 2004) . It was also proposed that the caveolin-1-Csk interaction mediated a feedback loop to regulate Src kinase activity in microdomains (Cao et al., 2004) . Two different complexes in the EGF signaling pathway, caveolin-1-Csk and Cbp-Csk, mediate two negative feedback loops 
Regulation of EGF-induced cell transformation by Cbp
LQ Jiang et al regulating SFK activity. Recently, it has reported that binding of Dok-R to Csk also forms a negative feedback loop to determine Src activation in EGF signaling (Van Slyke et al., 2005) . Interestingly, we found that Cbp interacted constitutively with caveolin-1, which is likely to be mediated by the FVITFLIF motif in the Cbp transmembrane domain, matching well with the published caveolin-binding motif cXXXXcXXc (c is an aromatic residue, like Trp, Phe, or Tyr) (Couet et al., 1997) . Caveolin-1, which is the structural protein of caveolae, appears to be a scaffold protein used for assembling multiple signaling molecules, including heterotrimeric G-proteins, Src family tyrosine kinases, endothelial nitric oxide synthase, Ha-Ras, and the EGF receptor (Okamoto et al., 1998) . The biological significance of the caveolin-Cbp interaction is currently unknown. It will be quite interesting to determine whether the interaction leads to a synergistic or complementary effect on SFK-mediated signaling, via the two negative feedbacks. Src family kinase is physiologically involved in numerous cellular actions. C-terminal Src kinase, as the major negative regulatory kinase for SFK, may be delicately regulated through its different binding partners. These regulations are very likely involved in Csk translocation and its mediated signaling to determine SFK activation in diverse regulatory systems of different cell types. Thus, there may be multiple and/or complementary negative feedback loops regulate SFK. Here, we demonstrated that when Cbp was expressed, the cell transformation in NIH3T3 cells and the formation of soft agar colonies in MDA-MB-468 cells were notably suppressed, possibly through reduction of Src activity. In contrast, when the CbpY317F mutation was overexpressed, cell transformation and soft agar colony formation were significantly enhanced (Figures 8  and 9 ). Furthermore, when the endogenous Cbp of NIH3T3 cells was downregulated by RNAi, the EGFinduced signal transduction and cell transformation was enhanced (Figures 7 and 8 ). These findings suggest that the endogenous Cbp participates in the negative regulation of EGF-induced signaling, cell transformation and oncogenesis.
The fact that Src and EGFR are both overexpressed in many of the same tumor types suggests that these two kinases may participate in regulating the genesis and/or progression of human cancers. It was shown that c-Src is required for EGF-induced mitogenesis in cultured murine fibroblasts (Wilson et al., 1989; Roche et al., 1995) , and that Src kinase inhibition reversed the transformation phenotype in EGFR-overexpressing NIH3T3 (Karni et al., 1999) . Dual overexpression of both Src and EGFR in C3H10T 1 2 mouse fibroblasts was found to lead to synergistic increases in EGFinduced DNA synthesis, soft agar colony formation, and tumor formation in nude mice, when compared with cells that expressed only one of the pair (Maa et al., 1995) .
MDA-MB-468 cells are well known for their overexpression and activation of EGFR. Multiple inhibitors of EGFR have been shown to suppress their proliferation (Rae and Lippman, 2004) or to induce apoptosis ( Lev et al., 2004) . In addition, many breast cancer cell lines, including MDA-MB-468, overexpress c-Src at levels fivefold or greater than immortalized normal breast epithelial cell lines (Biscardi et al., 1998) . Inhibiting endogenous c-Src in MDA-MB-468 cells with pharmacological inhibitors of the Src family, PP1, and PP2, or stable overexpression of the catalytically inactive c-Src mutant, diminished formation of soft agar colonies and tumors in nude mice . These findings indicate that both EGFR and Src are required to maintain the oncogenic phenotype of MDA-MB-468 cells. Overexpression of Cbp could boost up Cbp-Csk-mediated negative signaling in MDA-MB-468 cells, resulting in inhibition of anchorageindependent growth of the tumor cells.
In addition to inhibition of Src kinase activity, Cbp expression also suppressed EGF induction of ERK1/2 and Akt-1 activation in NIH3T3 and BHK/EGFR cells. Interestingly, expression of the Csk-binding deficient mutant of Cbp (CbpY317F) in BHK/EGFR cells augmented EGF-induced Src, ERK1/2, and Akt-1 activation. For unknown reasons, we only observed a significant augmentation of Akt-1, but not of Src or ERK1/2 in NIH3T3/CbpY317F stable cells. The different findings with BHK/EGFR and NIH3T3 cells may be related to the different expression levels of endogenous Cbp and/or different regulatory mechanisms for ERK1/ 2 activation in the two cell types. Nevertheless, the abolishment of Cbp's suppression of ERK1/2 and Akt-1 activation by point mutation at its Csk binding site (pY416), ERK1/2(pT202/pY204), and Akt-1(pS473) from three independent experiments (*Pp0.05, student's t-test). Only signals from EGF stimulated cells were quantified.
indicates that Cbp regulates these kinases through an interaction of Csk and Src. Although this point is in keeping with our model, it is worth mentioning that the Csk-binding deficient mutant of Cbp (CbpY317F) might also bind to other SH2 and/or SH3 domain-containing proteins to mediate additional downstream signaling.
Upon activation by EGF stimulation, Src activates the PI3-kinase/Akt pathway through both direct and indirect mechanisms (Jiang and Qiu, 2003; Kong et al., 2003; Lu et al., 2003) . Activation of the PI3-kinase/Akt pathway is essential for EGF-induced cell survival and migration (Franke et al., 2003; Shien et al., 2004) . Although Src is not the central component of the Ras/ MEK/MAPKs pathway controlling cell proliferation, it can promote EGF-induced ERK1/2 activation through PLCg-1 or Raf-1 (Mason et al., 1999; Bivona et al., 2003) . EGF-induced ERK1/2 activation was partially suppressed in cells treated with the Src family inhibitor, PP2 (Matsuoka et al., 2004) . In SHP2 knockout cells, EGF-induced ERK1/2 activation was enhanced by expression of the Csk-binding deficient Cbp mutant (Zhang et al., 2004) . These findings and the present report suggest that Cbp-Csk may negatively regulate EGFR-generated Ras/MEK/MAPKs and PI3-kinase/ Akt pathways indirectly, possibly through downregulation of Src activity, and participate in the suppression of tumor cell growth.
In addition to EGFR, expression of FGFR-1, TrkA, and PDGFR also induce strong tyrosine phosphorylation of Cbp in HEK 293 cells. In Shp2-deficient cells, overexpression of the Csk-binding deficient Cbp mutant increased PDGF-induced Src activation (Zhang et al., 2004) . As Src is involved in mediating signal transduction activated by multiple RTKs, such as FGFR-1, PDGFR, and TrkA (Yayon et al., 1997; DeMali et al., 1999; Tsuruda et al., 2004) , Cbp tyrosine phosphorylation by multiple RTKs indicates that controlling Src activity by the Cbp-Csk complex may serve as a general molecular mechanism for regulation of RTK-signaling pathways.
In conclusion, because Cbp has been implicated in negatively regulating Src, ERK1/2, and Akt-1 activation, the findings of the present investigation support a role for EGF-induced Cbp phosphorylation in the profile of cellular responses by which EGF receptor overexpression and its interaction with SFKs may potentiate cancer progression.
Materials and methods
Plasmids, antibodies and reagents Human Cbp gene was amplified from human placenta cDNA and cloned into the vector pcDNA3-VSV. pRK5 expression vectors with inserts encoding Csk, dominant-negative Csk (CskK222R), Src, dominant-negative Src (SrcK295R), EGFR, platelet-derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR)-1, and nerve growth factor receptor (TrkA) were gifts from Dr Axel Ullrich. Anti-Cbp and anti-Csk antibodies were obtained by immunizing rabbits with GST-Cbp (P261-L432) and GST-Csk (T12-E182) fusion proteins. The monoclonal anti-Cbp antibody was prepared against a Cbp fragment (P261-L432). Anti-Src, anti-ERK1/2, anti-Akt, anti-b-actin and anti-caveolin-1 antibodies were purchased from Santa Cruz Biotechnology. Anti-Src(pY416), anti-Src(pY527), anti-ERK1/2(pT202/pY204), and antiAkt(pS473) antibodies were ordered from cell signaling technology. Monoclonal antiphosphotyrosine (pY) antibody (4G10) was purchased from Upstate Technology. Anti-VSV antibody, EGF, octyl-D-glucoside and 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo(3,4-d)pyrimidine (PP2) were ordered from Sigma-Aldrich, St Louis, MO, USA.
Cell culture, transfection, retrovirus packaging, focus formation assay, and colony formation in soft agar Human epithelial carcinoma cell line A431, human embryonic kidney (HEK) 293 cell line and mouse fibroblast cell line NIH3T3 were obtained from ATCC. Retrovirus packaging cell line Bosc23, baby hamster kidney (BHK)-21 cells stably expressing EGFR (BHK/EGFR) and human breast cancer cell line MDA-MB-468 were gifts from Dr Axel Ullrich.
MDA-MB-468 cells were cultured in Leibovitz's L-15 medium (Gibco) with 10% fetal calf serum (FCS; Sigma). All other cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco) with 10% FCS. Transfection was performed with LipofectAMINE 2000 reagent (Invitrogen) following the manufacturer's instructions. For transient expression, cells were harvested 48 h after transfection. Retrovirus packaging was performed as described (Kharitonenkov et al., 1997) . NIH3T3 cells were plated in DMEM containing 10% FCS at a density of 1 Â 10 6 cells/60-mm plate. After 16 h, each plate was infected with 200 ml of virus supernatant (1 Â 10 6 CFU/ml) with 4 mg/ml polybrene for 4 h. Cells were transferred into DMEM containing 2% FCS and 5 ng/ml EGF. The medium was changed every other day. At 2 weeks after virus infection, foci were stained with 0.5% crystal violet and 20% methanol, and then counted. For the colony formation assay, a total of 10 000 MDA-MB-468 cells were suspended in 0.22% agar (Sigma Cat.No.A9915) dissolved in 4 ml Leibovitz's L-15 medium, which contained 10% FCS, and plated on top of 4 ml of 0.5% agar in 25 cm 2 flask. Cells were cultured at 371C for 3 weeks. Colonies composed of more than 100 cells were counted.
Epidermal growth factor stimulation, immunoprecipitation, immunoblot and pull-down assay Cells were serum-starved for 8 h, treated with 10 mM PP2 for 30 min when needed and either stimulated with 50 ng/ml EGF for 5 min or left untreated. The cells were then lysed in ODG buffer (50 mM Tris-HCl, pH 7.4, 1 mM EDTA, 1% Triton X-100, 2% octyl-D-glucoside, 5 mM b-mercaptoethanol, 0.25 M NaCl, 1 mM Na 3 VO 4 , 20 mM NaF, 10 mg/ml aprotinin, 10 mg/ ml leupeptin, 1 mM PMSF, and 5% glycerol). The cleared lysates were incubated with antibodies or GST-Csk fusion proteins coupled with protein A-sepharose or glutathionesepharose, respectively, for 3 h at 41C under rotation. The washed beads were separated on sodium dodecyl sulfatepolyacrylamide electrophoresis gels and transferred to membranes. For immunoblot quantification, membranes were exposed to X-ray film which was scanned and analysed using GS-800 Calibrated Densitometry and Quality One software (Bio-Rad Laboratories, Hercules, CA, USA).
Mutants and stable cell lines
The plasmid for expressing CbpY317F was constructed using the Quick Change site-directed mutagenesis kit (Stratagene) according to its manual. The forward primer is ATCAGC TATGTTCTCATCAGTAAATAAACCTG and the reverse primer is ATCTCTTCTTCTGTGAGAGTGG. For stable expression of wild-type Cbp (Cbp/wt) and CbpY317F in NIH3T3 and MDA-MB-468 cells, cells were transfected with 1 mg plasmid per 35 mm dish. After 48 h, cells were trypsinized and seeded in a 100 mm dish with selection medium (DMEM containing 750 mg/ml G418). The G418-resistent cells were selected and maintained in selection medium. Monoclonal cells were propagated from a single cell by diluting a pool of cells in a 96 well plate and picking out the well, which contained only one cell.
Preparation of caveolin-1-enriched microdomains Two different ways of purifying caveolin-1-enriched microdomains were carried out. The hypertonic sodium carbonate method was performed as described (Song et al., 1996) . Briefly, cells were washed with ice-cold PBS, scraped into 500 mM sodium carbonate (pH 11.0), solubilized for 20 min at 41C, homogenized with 10 strokes of a tight-fitting Dounce homogenizer, followed by three 20 s bursts of a sonication cell disrupter. Sucrose prepared in MBS (25 mM Mes, pH 6.5, 0.15 M NaCl) was added to the homogenates and placed at the bottom of an ultracentrifuge tube. The Triton X-100 based method was performed as described (Xu et al., 2005) . Briefly, cells were lysed in 0.05% Triton X-100 in TNEV buffer (150 mM NaCl, 5 mM EDTA, and 25 mM Tris-HCl, pH 7.4), followed by addition of an equal volume of 80% sucrose in lysis buffer. For both methods, 5 ml of 35% sucrose and 3 ml of 5% sucrose (both in MBS containing 250 mM sodium carbonate) were layered in sequence. After centrifugation at 39 000 r.p.m. for 20 h, in an SW40Ti rotor, 1 ml aliquots were sampled from above and analysed by Western blot.
Silencing of Cbp by RNA interference
We choose the mouse Cbp sequence from positions 1160-1180 (5 0 -AAGCCATACAGACTCTAAACA-3 0 ) as the target for RNA interference (RNAi) because its effectiveness has been proved in publication (Shima et al., 2003) . The corresponding human Cbp sequence from positions 1163-1183 (5 0 -AAGC GATACAGACTCTCAACA-3 0 ), which has two different nucleotides, was used as a control for the specificity of RNAi. The U6 promoter and multiple cloning sites from pSilencer 1.0-U6 small interfering RNA vector (Ambion, Austin, TX) was cut out and inserted into pcDNA3 vector. The nucleotide for RNAi was cloned into this modified pcDNA3 vector and then stably transfected into NIH3T3 cells. Regulation of EGF-induced cell transformation by Cbp LQ Jiang et al
